Stereotaxis Reports 2024 Second Quarter Financial Results
12 août 2024 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
12 août 2024 16h03 HE
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
22 juil. 2024 16h05 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 22, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18 juil. 2024 16h13 HE
|
Stereotaxis, Inc.
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum...
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
29 mai 2024 08h25 HE
|
Stereotaxis, Inc.
The most advanced robotic cardiac ablation lab opens at Penn Presbyterian Medical Center.
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
24 mai 2024 08h37 HE
|
Stereotaxis, Inc.
Stereotaxis has received CE Mark recertification under the EU’s new Medical Device Regulation (MDR) regulatory framework for all available devices.
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
22 mai 2024 08h42 HE
|
Stereotaxis, Inc.
Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
Stereotaxis Invited by Africa Heart Rhythm Association to Present its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
15 mai 2024 08h52 HE
|
Stereotaxis, Inc.
Stereotaxis presents innovative proposal leveraging advanced robotic technology and telerobotic presence to sustainably offer high-quality cardiac ablati
Stereotaxis Reports 2024 First Quarter Financial Results
13 mai 2024 16h03 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
13 mai 2024 16h02 HE
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has...